Please login to the form below
clinical trials
This page shows the latest clinical trials news and features for those working in and with pharma, biotech and healthcare.
Breath test could predict response to immunotherapy
It is currently being studied in more than 1, 000 clinical trials to support continued expansion into new cancer areas.
Latest news
-
Half of European cancer drug trials ‘biased’, says BMJ
Report says studies exaggerate benefits. A new study on clinical trials that supported European approvals for cancer drugs claims almost half could have been affected by bias that exaggerated their benefits. ... The European Clinical Trials Register (ECTR
-
Roche wins FDA breakthrough for Gazyva in lupus nephritis
Roche will also get a priority review for the drug, which can include additional clinical trials and other alternative information to support the application.
-
Sanofi exits Zynquista alliance with Lexicon
Issues surrounding the higher rate of diabetic ketoacidosis (DKA) in the SGLT arm of the clinical trial led to the complete rejection. ... The remainder will be payable within 12 months, and Sanofi will coordinate with Lexicon during the transition on
-
'Therapeutic overcrowding' could hit big pharma returns
Another problem is that with checkpoint inhibitors being tested in just about every type of cancer, there is a potential shortfall of patients required for clinical trials.
-
Finch Therapeutics bags $53m for microbiome therapies
Diff candidate. Like Finch, Rebiotix received a BTD from the FDA, and both companies have products in phase 3 clinical trials, which could make the race to market very close. ... Last June, Roche’s biotech division Genentech signed a $534m deal with
More from news
Approximately 161 fully matching, plus 1,621 partially matching documents found.
Latest Intelligence
-
How can we realise the benefits of patient engagement?
We need look no further than the major challenges currently faced by pharma at every stage of the product life cycle: clinical trials are delayed or discontinued because of issues with ... Without working with patients to develop therapy profiles, design
-
Encouraging signs in biomarker R&D
The timing of the withdrawal was ironic given that, in the same month, FDA Commissioner Scott Gottlieb highlighted ‘TMB as a potential biomarker for enriching clinical trials testing immunotherapies’. ... Clinical evolution. Greater use of biomarkers
-
A roadmap to the successful treatment of Alzheimer’s disease
These recent disappointments are painful – none more so, than for all the patients, families and doctors who participated in the clinical trials – but this is not a reason to abandon our ... At the same time, a lot of clinical trials are being
-
Spotlight on Patient Engagement
From clinical trials to the regulatory process and beyond, patient engagement should be a critical part of every drug’s development and its subsequent post-approval lifecycle.
-
Real-world studies
It can now be used to fill those gaps that randomised clinical trials (RCTs) have historically left when it comes to providing real-world data about a product in a ... With the right technology, infrastructure and support, RWD can be collected, stored,
More from intelligence
Approximately 11 fully matching, plus 163 partially matching documents found.
Latest appointments
-
New hires at Nanoform, Leo Pharma and Calliditas
and bringing products to market will play a key role as we progress development of Nefecon through phase 3 clinical trials”, said Renée Aguiar-Lucander, CEO of Calliditas Therapeutics.
-
Zelluna Immunotherapy appoints chief technology officer
His experience, acquired on both side’s of the Atlantic will provide invaluable for Zelluna in its immediate focus of delivering clinical proof of concept of its TCRs in adoptive cell ... He will play a big part in the execution of Zelluna’s
-
Neurocentrx appoints two members to the board
Brooksby said: “My focus is to accelerate the business model and drive commercial clinical trials to raise international awareness of what we are offering, and enter the global market.
-
Life Healthcare appoints two new starters
Joining Alisha is Caitlin McMaster (pictured right), who takes up an account executive role at Life Healthcare, working alongside the clinical trials team.
-
Topas Therapeutics appoints chief development officer and chief medical officer
Timm Jessen, chief executive officer, Topas, said: “Rupert has a long and successful track record of bringing drugs and biologics through clinical development and regulatory approval. ... At Topas, Dr. Sandbrink will guide projects into the clinic,
More from appointments
Approximately 0 fully matching, plus 61 partially matching documents found.
Latest from PMHub
-
Spotlight interview: 15 minutes on patient engagement in pharma
to some extent how the clinical trials are designed, and how the benefits are communicated to the public. ... What’s really interesting is the programmes now span a wide breadth: from projects looking at patient engagement in clinical trials, through
-
Battling breast cancer with precision medicine (Part 2)
I found a few clinical trials in the California area. Laura was eligible for one, which tested the PARP inhibitor and carboplatin, but there was another one in Los Angeles that ... Then we hit another hurdle; there was no clinical trial for that
-
My MS journey: one patient's search for innovation
David Lazarus charts his journey from initial MS diagnosis in 1990 to his experience participating in innovative clinical trials, along with his advice for other patients. ... The doctors there can refer you for clinical trials and then you have the
-
90TEN continues to expand its medical education team with six new hires
Nick Das moves into the role of Account Executive from his previous position as a Clinical Trials Manager at the University of Southampton, and James Wright, who has recently graduated from
-
Havas Lynx Group launches white paper on Clinical Trials Day to address $40bn clinical trials challenge
That is the clear message from Havas Lynx Group as it marks Clinical Trials Day (May 20. ... Clinical trials are broken and only patients can help fix them – if we let them.
More from PMHub
Approximately 18 fully matching, plus 86 partially matching documents found.
Featured jobs
-
Events Executive
-
DOE
-
Senior Medical Writer
-
Competitive salary plus benefits
-
Account Director – UK Office
-
Excellent salary and benefits
- Client Services Director- Flexible Working
-
Negotiable
- Account Manager – Healthcare advertising
-
Salary TBC
- Account Manager, Healthcare Communications
-
£32, 000 - £40, 000 bonus benefits
Subscribe to our email news alerts
- Novartis eyes potential new indication for Cosentyx
- J&J's Tremfya filed for approval in US for psoriatic arthritis
- Envision Pharma Group relocates to support expansion
- Biogen loses another pipeline drug to toxicity concerns
- AZ, Merck’s Lynparza scores market-expanding clinical success
- AbbVie/Allergan's merger faces public opposition
- How can we realise the benefits of patient engagement?
- Half of European cancer drug trials ‘biased’, says BMJ
- Four Health and ARK among winners at PM Society Digital Awards
- Democrats’ final pricing plan announced, 250 drugs targeted
- Insys gets bankruptcy court okay for Subsys sale
- Breath test could predict response to immunotherapy
PMHub
bmore group
OUR PROMISE: BETTER HEALTH FROM TRIAL TO TREATMENT.We are a full service, independent network of specialist agencies under one roof....
Latest intelligence
- Report: Customer experience, shaping digital healthcare
- In this issue of ‘Perspective’ we speak with industry experts to learn about the world of digital healthcare, and how pharma is beginning to utilise these modern technologies to enhance...
- Encouraging signs in biomarker R&D
- The cancer immunotherapy firms ramping-up biomarker R&D...
- Programmatic methodology and why you should be using it
- What is it? How does it work? Why is everyone talking about it? By Richard Webb - Associate Director...
Quick links
Infographics
